comparemela.com

Page 8 - Chris Howerton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Viridian Therapeutics, Inc (VRDN) CEO Jonathan Violin on Q1 2022 Results - Earnings Call Transcript

Viridian Therapeutics, Inc. (NASDAQ:NASDAQ:VRDN) Q1 2022 Earnings Conference Call May 12, 2022, 16:30 ET Company Participants John Jordan - VP, Investor Relations and Corporate.

Christopher howertonLaura chicoChris howertonJason butlerThomas smithJohn jordanKristian humerCompany participantsCorporate communicationsCorporate communications at viridianViridian therapeutics incViridian therapeuticsConference call mayInvestor relationsChief business officerPrincipal financial officer

Veru Inc s (VERU) CEO Mitchell Steiner on Q2 2022 Results - Earnings Call Transcript

Call End: Veru Inc. (NASDAQ:NASDAQ:VERU) Q2 2022 Earnings Conference Call May 12, 2022 8:00 AM ET Company Participants Samuel Fisch - Executive Director, Investor Relations and Corporate.

United statesUnited kingdomSouth africaMitchell steinerYi chenKumar rajaChris howertonLeland gershellGary barnetteMichael purvisSamuel fischSam fischMichele grecoBrandon folkesCompany participantsData safety monitoring committee

UroGen Pharma Ltd (URGN) CEO Liz Barrett on Q1 2022 Results - Earnings Call Transcript

UroGen Pharma Ltd. (NASDAQ:NASDAQ:URGN) Q1 2022 Earnings Conference Call May 10, 2022, 10:00 AM ET Company Participants Vincent Perrone - Senior Director of IR Liz Barrett - President and.

United statesMark jeffMatt kaplanChris howertonLiz barrettMark schoenbergUrogen pharmaLeland gershellRam selvarajuVincent perroneJeff bovaDon kimJennifer linehanAnita dushyanthCompany participantsLadenburg thalmann

Corcept Therapeutics (CORT) Q1 2022 Earnings Call Transcript

CORT earnings call for the period ending March 31, 2022.

United statesUniversity of chicagoNew jerseyCanaccord genuityChris howerton jefferiesMatt kaplanChris howertonCharles robbEdward nashCharlie robbJoseph belanoffAtabak mokariEdward nash canaccord genuitySean maduckMatt kaplan ladenburg thalmannGynecological oncology organization

Apellis Pharmaceuticals, Inc (APLS) CEO Cedric Francois on Q1 2022 Results - Earnings Call Transcript

Apellis Pharmaceuticals, Inc. (NASDAQ:NASDAQ:APLS) Q1 2022 Earnings Conference Call May 04, 2022, 16:30 ET Company Participants Meredith Kaya - SVP, IR & Strategic Finance Adam Townsend.

United statesJon millerRaymond jamesTim sullivanEliana merleMeredith kayaDerek archilaSteve seedhouseMadam townsendCedric francoisYigal nochomovitzLaura chicoChris howertonFederico grossiMadhu kumarJonathan miller

vimarsana © 2020. All Rights Reserved.